Atopic Dermatitis Market Key Player Profiles, Segment Breakdown, and Demand Forecast through 2024-2031

Global Atopic Dermatitis Market reached US$ 9.44 billion in 2023 and is expected to reach US$ 25.98 billion by 2031, growing at a CAGR of 13.7% during the forecast period 2024-2031.

Atopic Dermatitis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/atopic-dermatitis-market?sg

Atopic dermatitis, commonly known as eczema, is a chronic inflammatory skin condition characterized by itching, redness, and swelling. It belongs to the "atopic triad," along with allergic rhinitis (hay fever) and asthma. Often beginning in childhood, atopic dermatitis can persist into adulthood, with symptoms fluctuating over time. Chronic cases may lead to xerosis (dry, scaly skin), cracking, and even open sores. During flare-ups, symptoms worsen significantly, while periods of remission provide temporary relief.

The demand for atopic dermatitis treatments is rising due to increasing prevalence, particularly among children, and the need for more effective therapies. According to the Atopic Dermatitis Atlas Organization, the condition affects up to 20% of children and 10% of adults, ranking 15th globally among non-fatal diseases and first among skin diseases in disability-adjusted life years. As moderate-to-severe cases become more common, the market is seeing growing demand for advanced treatments beyond traditional topical therapies.

List of the Key Players in the Atopic Dermatitis Market: Pfizer Inc, Regeneron Pharmaceuticals Inc, Sanofi S.A, AbbVie Inc, Eli Lilly and Company, Galderma Inc, LEO Pharma Inc., Incyte Corporation, Arcutis Biotherapeutics, Inc and Otsuka Pharmaceutical Co., Ltd.

Industry Development:

In April 2024, Dermavant Sciences released that the U.S. Food and Drug Administration (FDA) accepted the company's Supplemental New Drug Application (sNDA) for VTAMA (tapinarof) cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children 2 years of age and older. The Prescription Drug User Fee Act ("PDUFA") action date assigned by the Agency is in Q4 2024.

In July 2024, Arcutis Biotherapeutics, Inc. cleared that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for ZORYVE (roflumilast) cream, 0.15%, for the treatment of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older. ZORYVE is a once-daily, steroid-free cream that provides rapid disease clearance and significant reduction in itch and has been specifically developed to be a treatment option for long-term disease control.

Growth Forecast Projected:

The Global Atopic Dermatitis Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Atopic Dermatitis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/atopic-dermatitis-market?sg

Segment Covered in the Atopic Dermatitis Market:

By Treatment Type (Corticosteroids, Antihistamines, Immunomodulators, Biologic Therapy, Others)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Atopic Dermatitis Market:

The regional analysis of the Atopic Dermatitis Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Browse More Reports:

Atopic Dermatitis Drugs Market -https://www.datamintelligence.com/research-report/atopic-dermatitis-drugs-market?sg

Canine Atopic Dermatitis Market - https://www.datamintelligence.com/research-report/canine-atopic-dermatitis-market?sg

China Acne and Atopic Dermatitis Dermocosmetic Market - https://www.datamintelligence.com/research-report/china-acne-and-atopic-dermatitis-dermocosmetic-market?sg

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Atopic Dermatitis market?

➠ Who are the leading manufacturers in the global Atopic Dermatitis industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Atopic Dermatitis industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Atopic Dermatitis market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.